What is Primera Analytical Solutions?
Primera Analytical Solutions is a global provider of specialized analytical services for the pharmaceutical and biologic industries. The company focuses on supporting small, mid-size, and large pharmaceutical firms throughout the critical drug development lifecycle. Their comprehensive service portfolio includes small molecule CMC, biopharmaceutical products CMC, cell and gene therapy development, and a broad spectrum of bioanalytical services. By emphasizing quality, regulatory adherence, and flexible solutions, Primera positions itself as a trusted partner, facilitating the efficient and timely market entry of life-saving therapeutics. Their deep scientific expertise is a cornerstone of their value proposition.
How much funding has Primera Analytical Solutions raised?
Primera Analytical Solutions has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in Primera Analytical Solutions
PPP
Public-Private Partnership
What's next for Primera Analytical Solutions?
The recent major strategic investment signals a pivotal growth phase for Primera Analytical Solutions. This capital infusion is expected to fuel further expansion of its service offerings, enhance its technological capabilities, and potentially broaden its market reach. As a key player in drug development support, the company is well-positioned to capitalize on the increasing demand for specialized analytical services, particularly in complex areas like cell and gene therapy. Future developments will likely focus on scaling operations to meet growing client needs and solidifying its role as an indispensable partner in bringing innovative medicines to patients.
See full Primera Analytical Solutions company page
